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Exposure to multiple chemicals may cause significant alterations of tissue dose of the toxic moiety of one or more of the individual chemicals.
The change in target tissue dose of a chemical present in simple mixtures can be predicted when the determinants of disposition of each chemical,
and the mechanism of toxicokinetic interaction between chemicals are understood at a quantitative level. Determinants of disposition include
physiological (e.g., breathing rates, cardiac output, tissue volumes, blood flow rates), biochemical (e.g., kinetic constants for metabolism and protein
binding), and physicochemical factors (e.g., blood:air and tissue:blood partition coefficients). Mechanisms of toxicokinetic interactions refer to the
manner in which coexposure alters these determinants of disposition as compared to exposure to the individual chemicals. Interactions between
chemicals can be described quantitatively with physiologically based pharmacokinetic (PBPK) models, which integrate these mechanistic
determinants and permit prediction of alterations in tissue dose for various exposure situations by computer simulation. PBPK modeling studies of
binary chemical interactions conducted so far indicate that inhibitory rather than potentiating metabolic interactions are more likely to be observed
during multiple chemical exposures. As PBPK models of representative binary, tertiary and quaternary mixtures are developed, it will become
increasingly possible to draw reliable conclusions about the risk associated with human exposure to chemical mixtures. -Environ Health Perspect
102(Suppl 9):151-155 (1994)
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Introduction
Multichemical exposure is the rule rather
than the exception in both the general and
occupational environments. Simultaneous
or sequential exposure to multiple chemi-
cals may alter the toxicokinetics and/or
toxicodynamics of one or all of them. This
can lead to a quantitative alteration of the
toxicity predicted based on the summation
of the effects of the components. Toxi-
cokinetic interactions occur when the tissue
dose of the active chemical per unit of ex-
posure is altered by co-exposure to other
chemicals. Toxicodynamic interactions
occur when tissue response to a unit tissue
dose ofthe active chemical is altered by co-
exposure to other chemicals. When interac-
tions occur among components of a
chemical mixture, the mechanistic basis of
such interactions should be understood at a
quantitative level to conduct risk assess-
mnent for the chemical mixture. The uncer-
tainties arising from changes in the
toxicokinetics of the components can be
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addressed by developing physiologically
based pharmacokinetic models ofchemical
mixtures which can be used for dose, route,
and species extrapolations of target tissue
concentrations ofthe toxic moieties. This
paper presents a short overview of the
basics ofphysiologically based pharmacoki-
netic modeling and some examples of its
use in the mechanistic analyses oftoxicoki-
netic interactions occurring in chemical
mixtures.
Physiologically Based
Pharmacokinetic Modeling
Physiologically based pharmacokinetic
(PBPK) modeling is the process ofdevelop-
ing mathematical descriptions of the
uptake and disposition of chemicals in
which the interrelationships among the
critical biological determinants are
described as realistically as possible. In the
PBPK modeling approach, the body is
divided into a number of tissue compart-
ments (Figure 1), each ofwhich is defined
by appropriate volume, blood flow rates
and solubility characteristics. The compart-
ments may represent a single tissue or a
grouping oftissues that have similar blood
flow and solubility characteristics. In the
PBPK models, the rate oftissue uptake ofa
chemical is described either as a blood flow
limited uptake or limited by diffusion from
blood into the tissue (1). For blood flow
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pharmacokinetic model for styrene. Qterms are air and
blood flow rates; C terms are concentrations. These
are indexed to individual tissue compartments: fat (f),
muscle (n), richly perfused tissues (r) and liver (I).
Effluent venous concentrations have a double lettered
subscript. 0aiv and Qt are alveolar ventilation and car-
diac output. The subscripts inh, alv, art, and yen signify
inhaled air, exhaled air, arterial blood, and venous
blood, respectively. Kinetic constants for liver metabo-
lism are Vmax (maximum rate of metabolism) and Km
(binding affinity of the substrate with metabolizing
enzyme). From Ramsey and Anderseti (28), reproduced
with permission of Academic Press.
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limited uptake, the rate ofchange in the
amount ofa chemical in the tissue (dAt/dt)
is described with a mass balance differential
equation, which accounts for the roles of
tissue blood flow rates (Q,), arteriovenous
concentration difference (C6-Ct), and tis-
sue metabolism
dA4t/dt = Qt(Ca7(,) - d4met/dt
[1]
Metabolism in individual tissues or tis-
sue groups can be included by adding
appropriate terms, to account for the
amount lost by metabolism, which might
be a first or second order process (e.g., glu-
tathione conjugation), or a saturable
process (e.g., cytochrome P450 mediated
oxidation) as follows
dAmetldt = Vm.Cvt/(Km+ C,+,) + KfCvtVt
[2]
where
Vmax = Maximum enzymatic reaction rate
(mg/hr)
Km = Michaelis constant for enzymatic
reaction (mg/I)
Kf= First order rate constant (hr-1)
Vt = Volume ofthe tissue (1)
The total amount of the chemical in
the tissue (At) then is calculated by inte-
grating the mass balance differential
equation (Equation 1). The tissue concen-
tration ofthe chemical at any time is calcu-
lated by dividing the amount in the tissue
by tissue volume.
Three types ofparameters are required
to develop PBPK models: physiological
(e.g., alveolar ventilation rate, blood flow
rate, tissue volumes, glomerular filtration
rate), biochemical (e.g., Vmax, Km) and
physicochemical (e.g., blood:air and tis-
sue:blood partition coefficients). Partition
coefficients ofvolatile organic chemicals
can be determined by vial equilibration
(2). Physiological parameters can be
obtained from biomedical literature (3).
Biochemical parameters related to metabo-
lism and protein binding can be deter-
mined either in vitro or u,sing noninvasive
in vivo exposure techniques such as gas
uptake and exhaled breath techniques for
metabolic parameters (4). Once formu-
lated by integrating the information on
animal physiology, rate constants for
kinetic processes and partition coefficients,
the PBPK model can be used to simulate
the kinetic behavior of a chemical in the
test species for avariety ofexposure scenar-
This type of PBPK model has been
developed for a number of individual
chemicals (4). The principal application of
this biologically and mechanistically based
approach is in the prediction oftarget tis-
sue dose ofthe toxic parent chemical or its
reactive metabolite. Using the tissue dose
of the toxic moiety ofa chemical in risk
assessment provides a better basis ofrelat-
ing to the observed toxic effects than the
external exposure concentration (5).
Because PBPK models facilitate the predic-
tion of target tissue dose in people, they
can help reduce the uncertainty associated
with the conventional extrapolation proce-
dures (6).
PBPK Modeling of Simple
Mixtures
When animals and people are exposed to
two chemicals there may or may not be an
interaction between the chemicals. Toxic
interactions result from the modulation of
the toxicokinetics and/or toxicodynamics
ofone chemical by another. Toxicokinetic
interactions involve modulation of the
absorption, distribution, metabolism, and
excretion ofone chemical by another via
alterations in the physicochemical, physio-
logical, and biochemical parameters. PBPK
modeling studies ofchemical mixtures can
significantly improve our ability to investi-
gate mechanisms oftoxic interactions in
vivo in a quantitative manner, and can be
used to conduct dose, route, and species
extrapolations ofthe target tissue dose of
the toxic moieties ofthe chemicals in the
mixture.
For PBPK modeling of binary mix-
tures, the influence ofone chemical on the
other should be considered in terms ofthe
alteration of critical biological determi-
nants of disposition by the coexposure.
Combined chemical exposures may affect
(a) physicochemical parameters, (b) physi-
ological parameters and (c) biochemical
parameters, which necessarily determine
the disposition ofboth chemicals, and their
target tissue dose.
PhysicocemicalParameters
During combined exposure scenarios, one
chemical may alter the solubility character-
istics ofanother chemical. For example,
cyanide forms complexes with essential
metals resulting in a change in their tissue
concentrations and distribution pattern
(7-10) due to changes in solubility and
stability (11,12). Similarly, various dithio-
carbamates form lipophilic complexes with
inorganic lead, enhancing lead uptake
across the blood-brain barrier, thus causing
a greater accumulation in the lipid-rich
brain compartments (13). However, the
tissue:air and blood:air partition coeffi-
cients ofcertain volatile organic chemicals
have been found to remain unaltered dur-
ing combined exposures (14). These
chemicals still interact by mechanisms that
involve changes in the biochemical and
physiological parameters.
Physiological Parameters
Physiological parameters include tissue vol-
umes (Vt), breathing rates (Qp), cardiac
output (Qc), blood flow rates (Qt),
glomerular filtration rate (GFR), etc. Ifone
chemical in a simple mixture alters one of
the physiological parameters, then that
chemical can be expected to alter the dis-
position and target tissue dose of other
components in the mixture (15). For
example, repeated administration ofphe-
nobarbital causes enlargement ofthe liver
(i.e., increases the model parameter V),
and alters liver blood flow rates (in addi-
tion to altering the biochemical parame-
ters). Ethanol causes alterations ofhepatic
blood flow rates (QI) and cadmium alters
the GFR. Hydrogen sulfide and hydrogen
cyanide at low exposure concentrations
cause increases in Qp, thus increasing the
respiratory uptake (and therefore the
toxicity) of other chemicals. For these
observations to be incorporated into a phy-
siological modeling framework to predict
their effect on the disposition of other
chemicals, dose-response information (e.g.,
Ql, Qp, 4, GFR versus exposure concen-
tration) is needed. With environmental
chemicals, the most common single mech-
anism of interaction investigated in such
detail appears to be the modulation ofbio-
chemical parameters (15).
BiochemicalParameters
Biochemical parameters include the rate
constants ofmetabolism, and the affinities
and capacities of protein binding. The
effects ofcombined exposure to chemicals
on their metabolism might be a result of
their competition for enzymatic binding
sites, or might be due to one chemical
inducing the enzyme system implicated in
the metabolism ofthe other.
Enzyme induction has been modeled
by taking into account the altered Vma. or
Kf due to treatment with the inducer.
Induction should not alter the Km if the
same isoform is induced. Andersen et al.
(16) modeled the effect ofprior adminis-
tration ofstyrene (1000 ppm for 6 hr/day
for4 days) or phenobarbital (80 mg/kg/day
for 4 days prior to styrene exposure) on the
metabolism ofstyrene. Pretreatment with
phenobarbital increased the Vm. by a fac-
tor ofsix; styrene pre-exposures increased
Vma, by a factor of 2. These observations
were consistent with a role for a high affin-
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Figure 2. Relationship between the rate of uptake of
styrene from inhaled air and the arterial blood concen-
tration of styrene at the end of a 6-hr exposure.
Pretreatments used were pyrazole, 320 mg/kg, 30 min
before initiating exposure, and phenobarbital, 80
mg/kg/day on each of 4 days preceding styrene expo-
sure. The styrene pretreatment was daily exposure to
1000 ppm for 6 hr on each of the 4 days before test
exposure to the various concentrations. From Andersen
et al. (16)with permission ofthe Academic Press.
ity enzyme in the metabolism ofstyrene,
and indicated that the inducer pretreat-
ments did not enhance styrene metabolism
at low exposure concentrations (<200
ppm). A curve fitting routine was
employed with the PBPK modeling
approach to describe the kinetics of the
enzyme induction process. This modeling
aspect was based on a) basal Vmax for
styrene metabolism in naive rats, b) time
lag for induction, c) incremental increase in
Vmax, and d) a rate constant for the
induction process. More recently, the influ-
ence of enzyme induction by several
substances (phenobarbital, Mirex, and
chlordecone) on the metabolism of
BrCCl and by ethanol on the metabolism
oftrichloroethylene have been described
within a physiological modeling framework
(17,18). At low exposure concentrations
(i.e., when hepatic blood flow limits
metabolism), the effect ofenzyme induc-
tion will be negligible. In these instances,
interactive effects could still be important if
they involve metabolic inhibitions.
For elucidating the mechanism ofmeta-
bolic inhibition, the mass balance differen-
tial equation of the metabolizing tissue
(e.g., liver) has to be modified to accom-
modate various hypotheses (Table 1). The
predictions ofthe PBPK model with each
mechanistic description are then compared
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Figure 3. Model simulations of the area under the
blood 2,5-hexanedione concentration vs time curve for
6- and 12-hr inhalation exposures of up to 10,000 ppm
n-hexane. The solid lines were generated with a PBPK
model assuming competitive interactions among n-
hexane, 2,5-hexanedione and methyl n-butyl ketone.
with experimental data on both chemicals
obtained during coexposures, to test the
validity ofthe hypotheses. Using the PBPK
modeling approach, Andersen and Clewell
(19) described the toxicokinetic interaction
among n-hexane and its metabolites.
n-Hexane is metabolized by a saturable
pathway yielding methyl n-butyl ketone
(MnBK). MnBK is further metabolized by
c0-1 oxidation to 2,5-hexanedione, the
neurotoxic metabolite, and by a-oxidation
and decarboxylation to pentanoic acid.
Following a 6-hr exposure ofF-344 rats to
500, 1000, 3000, and 10,000 ppm of
n-hexane, the blood concentrations of
n-hexane and MnBK increased linearly
with increasing exposure concentrations,
but 2,5-hexanedione (HD) showed
anamolous behavior (20). The concentra-
tion of HD at the end ofhexane exposure
increased substantially from 500 to 1000
ppm, then remained fairly constant
between 1000 and 3000 ppm but was
lower for the 10000 ppm n-hexane expo-
sure than for the lower exposure levels. At
high hexane exposure concentrations, the
blood level of HD immediately following
hexane exposure was lower than the even-
tual peak, indicating that inhibition ofHD
20
16
. DBM ALONE 0 0 (2O0Opp)
12 0
O 0.
8 0 DBM a* S (200Opp. +
4 S _ .0
+ IOp)
0 2 4 6 8 10
TIME (hr)
Figure 4. Model predictions (solid lines) and experi-
mental observations (symbols) of carboxyhemoglobin
levels during and following combined exposure to
dichloromethane and isofluorene. In the PBPK model,
the hepatic metabolism of both chemicals was
described as a competitive inhibition process. From
Clewell and Andersen (6); with permission of
Princeton Scientific Publishing Inc.
production during hexane exposure ceased
with the termination ofhexane exposure.
In addition, the time at which the peak
HD concentration occurred was immedi-
ately after exposure at lowest exposure con-
centrations, but not until 6 hr later for the
highest exposure concentration. In model-
ing this complex kinetic behavior of HD
resulting from hexane exposure, Andersen
and Clewell (19) considered multiple com-
petitive interactions among n-hexane,
MnBK, and HD. This PBPK description
consistent with the observed kinetics of
n-hexane, MnBK and HD predicted a peak
toxicity (corresponding to the increased
AUC of HD) of n-hexane at 1000 ppm
(Figure 3) and also suggested that both at
higher concentrations and continuous
exposures, n-hexane might actually be less
toxic due to lower conversion to 2,5-HD
than at intermediate concentrations and
intermittent exposures. In the hexane
model, HD and MnBK were also capable
ofinhibiting n-Hexane metabolism.
Inhibitory interactions similar to those
occurring between hexane and MnBK, and
HD can also occur during exposure to a
binary mixture of the chemicals if the
chemicals have similar properties. The
Table 1. Metabolic inhibition mechanisms and the corresponding equations used in the PB-PK models.
Inhibition type Equation
None Vmaxl x Cv, /(Km1 + C1)
Competitive Vmaxl X Cvl /(Km1 x (1 +Cv2/K,21) +Cvl)
Uncompetitive Vmaxl x Cvl /(Km8 +Cvl x(1 +Cv2j)
Noncompetitive Vmax xCvl /((Km +Cvl) x l +CvA/Zl))
These equations arewritten forchemical 1 as substrate and chemical 2 as inhibitor.
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Figure 5. trans-1,2-Dichloroethylene uptake by groups
of three F-344 rats placed in a closed, recirculated
chamber with starting concentrations of 12, 8, or 5
ppm. Experimental data are shown as symbols and
model simulations are presented as solid lines. The
systematic discrepancy between the model and the
data provided an indication that the simple description
of metabolism in the model was inadequate for this
chemical. From Clewell and Andersen (25); with per-
mission ofthe National Academy of Sciences.
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Figure 6. 1,2-Dichloroethylene uptake by groups of
three F-344 rats placed in a closed, recirculated cham-
ber with starting concentrations of 12, 8, or 5 ppm.
Experimental data are shown as symbols and model
simulation is presented as solid lines. In this case, the
model description accounted for enzyme inactivation by
reactive metabolites assumed to be produced during
the metabolism oftrans-dichloroethylene. From Clewell
and Andersen (25) with permission of the National
Academy of Sciences.
inhibitory chemical (equivalent to hexane)
needs to have a low partition coefficient
and be rapidly eliminated by exhalation at
cessation of the co-exposure period. The
metabolized component (equivalent to
MnBK) should have a greater solubility
and persist in the body after the exposure is
halted. To facilitate the study, metabolite
(equivalent to HD) should readily be mea-
surable. Clewell and Andersen (6) devised
a mixture of isoflurane (ISO) and dibro-
momethane (DBM). DBM, a tissue-solu-
ble vapor, is metabolized to carbon
monoxide. During exposure ISO inhibits
DBM conversion to CO. After exposure
ISO is eliminated more rapidly than DBM
and CO production is enhanced. The com-
plex behavior ofcarboxyhemoglobin, like
that of HD, occurs due to differential
blood:air partition coefficients ofthe com-
peting substrates (Figure 4).
Inhibitory metabolic interactions
between trichloroethylene and dichloroeth-
ylene, benzene and toluene, and m-xylene
and toluene have also been described with
a physiological modeling approach
(21-23). In these studies, the metabolic
rate constants for each chemical were first
determined byconducting gas uptake stud-
ies with individual chemicals, and then the
metabolic inhibition constants were deter-
mined by conducting another series ofgas
uptake studies with both chemicals. The
binary chemical gas uptake data indicating
altered uptake of both chemicals during
coexposures were analyzed with a PBPK
model to test various hypotheses ofinhibi-
tory interaction (e.g., competitive, non-
competitive, uncompetitive). These studies
considered the metabolic rate constants to
be time-invariant. There are instances
where such a description may not be suffi-
cient, especially where inactivation of
metabolizing enzymes occurs during the
exposure.
Andersen et al. (24) found that the
decline in the gas uptake chamber concen-
tration ofboth cis- and trans- 1,2-dichloro-
ethylene could not be described with time-
invariant metabolic constants (Figure 5).
This indicated that the maximum rate of
metabolism was decreasing during exposure
to these compounds. The gas uptake data
was successfully described by a PBPK
model in which the rate ofenzyme inacti-
vation was proportional to a second order
rate constant (Kd) times the square ofthe
instantaneous rate ofmetabolism (Figure
6). The square dependence on instanta-
neous metabolic rate indicated an interac-
tion between a reactive metabolite and the
enzyme-substrate complex in the rate limit-
ing step for enzyme inactivation (25,26).
Ofthe two chloroethylenes, the trans iso-
mer is a much better suicide inhibitor than
the cis isomer (Kd: 400 vs 1.2). Inhibition
by trans-1,2-dichloroethylene occurs at low
exposure levels (5 ppm), and may be signif-
icant in various exposure situations.
Future Directions
Binary chemical mixtures are a great sim-
plification ofthe real world situations. The
toxicokinetics and toxicodynamics of two
interacting chemicals might further be
altered by other components in more
complex mixtures. With multichemical
mixtures, some components may act inde-
pendently, neither interfering with nor
being modified by other chemicals, whereas
others might interfere with and modify the
toxicity ofother chemicals. With environ-
mental chemicals, toxic interactions mainly
appear to involve alteration ofbiochemical
parameters (15). If metabolic inhibitory
interaction occurs among the components
ofa multichemical mixture, the modeling
of such a phenomenon can be accom-
plished by approaches similar to those uti-
lized for binary chemical mixtures (27).
Another area that deserves more consid-
eration is the role of multiple forms of
cytochrome P450 each of which may
metabolize a given chemical with distinct
affinity and capacity. PBPK modeling of
multiple chemicals metabolized to varying
extents by several isoenzymes will be more
complicated with various mixed type inhi-
bitions, rendering the discrimination
between mechanistic descriptions difficult.
In summary, physiologically based
modeling approaches facilitate predictions
ofchange in the target tissue concentra-
tions of toxic moiety ofchemicals present
in simple mixtures, when the mechanisms
ofdisposition and interaction are under-
stood at a quantitative level. The PBPK
analyses ofsimple mixtures conducted to
date indicate that the effects of enzyme
inactivators, such as trans-1,2-dichlo-
roethylene, are likely to be observed
in occupational and perhaps in certain
environmental exposure situations. On the
contrary, the interactive effects ofenzyme
inducers such as ethanol and styrene will be
important only at much higher exposure
concentrations. As PBPK models ofrepre-
sentative binary, tertiary and quaternary
mixtures are developed, it will become
increasingly possible to draw reliable con-
clusions about the risk associated with
human exposures to chemical mixtures.
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